Haemonetics swings to Q1 red, lowers full-year guidance; Wall Street flees

July 29, 2013 by Sony Salzman

Haemonetics takes a hard dive on Wall Street after posting lackluster Q1 financial results and lowering its full-year 2014 expectations.

Haemonetics slips to red in Q1 2014

Haemonetics Corp. (NYSE:HAE) took a Wall Street dip after posting a hard swing to the red and adjusted per-share earnings just shy of analysts' expectations.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.